Overview

Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Status:
NOT_YET_RECRUITING

Trial end date:
2026-11-01

Target enrollment:

Participant gender:

Summary

The goal of this cluster randomized controlled trial is to determine the optimal treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 40 years old diagnosed with chronic obstructive pulmonary disease with acute exacerbation. The main question is whether there is a difference in readmission for COPD excerbation or all cause mortality within thirty days. Participants will randomized to receive treatment with either hydrocortisone or prednisolone.

Phase:

PHASE4

Details

Lead Sponsor:

Copenhagen Respiratory Research

Treatments:

Hydrocortisone
Methylprednisolone
Pharmaceutical Preparations